Isabel López
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Isabel López has a total of 10 co-authors. Here are the top co-authors by number of shared publications:
- Natsuki Oishi
Faculty of Medicine and Odontology, Valencia University, 46010 Valencia, Spain
3 shared publications Enrique Zapater
Valencia Medical School University General Hospital of Valencia Valencia Spain
2 shared publicationsAinhoa García‐Lliberós
ENT Department, Valencia University General Hospital and Manises Hospital, Valencia, Spain
1 shared publicationAlvaro Sánchez
ENT Department University General Hospital of Valencia Valencia Spain
1 shared publication- Enrique Zapater
Faculty of Medicine and Odontology, Valencia University, 46010 Valencia, Spain
1 shared publication - Isabel García López
ENT Department, Hospital Universitario La Paz, Madrid, Spain
1 shared publication
Latest Publications
- 5 November 2023
- Published by Wiley in Clinical Otolaryngology
- Vol. 49 (2) , 185-190
Validation of the 10‐Item Unilateral Vocal Fold Paralysis‐Handicap Index quality of life questionnaire
Objectives: To validate and test the reliability of the 10‐Item Unilateral Vocal Fold Paralysis‐Voice Handicap Index (UVFP‐HI‐10) quality of life (QoL) questionnaire for patients with UVFP.Design: Prospective describe study based on perceptive surveys.Participants: We recruited 61 patients with UVFP and 53 healthy individuals comprised the control group.Main Outcome Measures: Both the patients and controls completed the UVFP‐HI‐10 questionnaire. A statistical analysis was performed to assess the internal consistency and validity of the survey. In addition, maximum phonation time (MPT) was used to objectively measure patient QoL.Results: Internal consistency was high (α = .914) and the correlation with MPT was significant (rs = −0.722). The estimated marginal mean in the discriminant validity study was around seven times higher in the UVFP group compared to the controls. The UVFP‐HI‐10 cut‐off value was more than 0.9 and the sensitivity and specificity were more than 0.8.Conclusions: The UVFP‐HI‐10 is a self‐administered patient‐reported outcome questionnaire with a high reliability and excellent criterion‐based validity. This questionnaire can be used to evaluate specific clinical complaints (e.g., vocalisation, swallowing, and breathing) in terms of their impact on QoL in patients with UVFP. Thus, its use is appropriate as a basic assessment tool as part of a specific UVFP treatment protocol.
- 5 November 2023
- Published by Wiley in Clinical Otolaryngology
- Vol. 49 (2) , 185-190
Validation of the 10‐Item Unilateral Vocal Fold Paralysis‐Handicap Index quality of life questionnaire
Objectives: To validate and test the reliability of the 10‐Item Unilateral Vocal Fold Paralysis‐Voice Handicap Index (UVFP‐HI‐10) quality of life (QoL) questionnaire for patients with UVFP.Design: Prospective describe study based on perceptive surveys.Participants: We recruited 61 patients with UVFP and 53 healthy individuals comprised the control group.Main Outcome Measures: Both the patients and controls completed the UVFP‐HI‐10 questionnaire. A statistical analysis was performed to assess the internal consistency and validity of the survey. In addition, maximum phonation time (MPT) was used to objectively measure patient QoL.Results: Internal consistency was high (α = .914) and the correlation with MPT was significant (rs = −0.722). The estimated marginal mean in the discriminant validity study was around seven times higher in the UVFP group compared to the controls. The UVFP‐HI‐10 cut‐off value was more than 0.9 and the sensitivity and specificity were more than 0.8.Conclusions: The UVFP‐HI‐10 is a self‐administered patient‐reported outcome questionnaire with a high reliability and excellent criterion‐based validity. This questionnaire can be used to evaluate specific clinical complaints (e.g., vocalisation, swallowing, and breathing) in terms of their impact on QoL in patients with UVFP. Thus, its use is appropriate as a basic assessment tool as part of a specific UVFP treatment protocol.
- 26 July 2021
- Published by Wiley in Head & Neck
- Vol. 43 (10) , 3245-3248
Use of monopolar microelectrodes and radiofrequency in the treatment of arytenoid edema after partial horizontal laryngectomy and radiotherapy
We evaluated the tissue reduction effects using monopolar microelectrodes (MME) coupled to a radiofrequency (RF) generator in arytenoid edema caused by postoperative radiotherapy in larynx. This is a retrospective transversal study, which included 15 patients with supraglottic laryngeal carcinoma. All the patients had undergone a partial horizontal laryngectomy and bilateral neck dissection followed by postoperative radiotherapy. The studied group of patients presented laryngeal stenosis defined by arytenoid edema as a complication, requiring permanent tracheostomy for mean of 12 months. The surgical procedure for treating the edema was the transoral approach of the larynx by microlaryngoscopy under general anesthesia; using 180° MME coupled to a 4‐MHz RF generator delivering 15 W using coagulation mode. A total of 11 (73%) patients were decannulated. The median time for decannulation was 10 weeks. No complications were reported. After 2 years of follow‐ups, no case of re‐stenosis was found. MME coupled to RF is a very efficient method to treat arytenoid edema after adjuvant radiotherapy.
- 26 July 2021
- Published by Wiley in Head & Neck
- Vol. 43 (10) , 3245-3248
Use of monopolar microelectrodes and radiofrequency in the treatment of arytenoid edema after partial horizontal laryngectomy and radiotherapy
We evaluated the tissue reduction effects using monopolar microelectrodes (MME) coupled to a radiofrequency (RF) generator in arytenoid edema caused by postoperative radiotherapy in larynx. This is a retrospective transversal study, which included 15 patients with supraglottic laryngeal carcinoma. All the patients had undergone a partial horizontal laryngectomy and bilateral neck dissection followed by postoperative radiotherapy. The studied group of patients presented laryngeal stenosis defined by arytenoid edema as a complication, requiring permanent tracheostomy for mean of 12 months. The surgical procedure for treating the edema was the transoral approach of the larynx by microlaryngoscopy under general anesthesia; using 180° MME coupled to a 4‐MHz RF generator delivering 15 W using coagulation mode. A total of 11 (73%) patients were decannulated. The median time for decannulation was 10 weeks. No complications were reported. After 2 years of follow‐ups, no case of re‐stenosis was found. MME coupled to RF is a very efficient method to treat arytenoid edema after adjuvant radiotherapy.
- 12 September 2019
- Published by Wiley in Clinical Otolaryngology
- Vol. 44 (6) , 1162-1165
Use of individual anatomical variations to customise window location in montgomery implant thyroplasty: A case series study
- 12 September 2019
- Published by Wiley in Clinical Otolaryngology
- Vol. 44 (6) , 1162-1165
Use of individual anatomical variations to customise window location in montgomery implant thyroplasty: A case series study